Cardiac concerns associated with strontium ranelate (Q34336113)

1 August 2017

3 references

17 June 2019

17 September 2019

16 July 2021

Cardiac concerns associated with strontium ranelate (English)

1 reference

bone density conservation agents

1 August 2017

cardiovascular disease

2 references

17 June 2019

17 September 2019

heterocyclic compound

1 reference

17 September 2019

1 reference

1 reference

16 July 2021

1

Jean-Yves Reginster

1 reference

PubMed ID

25020233

1 August 2017

language of work or name

English

0 references

publication date

14 July 2014

1 reference

PubMed ID

25020233

Expert Opinion on Drug Safety

1 August 2017

1 September 2014

3 references

17 June 2019

17 September 2019

16 July 2021

4 references

1 August 2017

17 June 2019

17 September 2019

16 July 2021

13

1 reference

1 August 2017

1209-1213

1 reference

1 August 2017

9

1 reference

Creative Commons Attribution 3.0 Unported

1 August 2017

3 references

17 June 2019

17 September 2019

Ischaemic cardiac events and use of strontium ranelate in postmenopausal osteoporosis: a nested case-control study in the CPRD.

16 July 2021

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4196504

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4196504

Adverse drug reactions to osteoporosis treatments

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4196504

Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4196504

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4196504

Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4196504

Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4196504

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4196504

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4196504

Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men.

6 July 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.939169

Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.939169

Use of strontium ranelate and risk of acute coronary syndrome: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.939169

Cardiovascular safety of strontium ranelate: real-life assessment in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.939169

A large prospective European cohort study of patients treated with strontium ranelate and followed up over 3 years

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25020233

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1517/14740338.2014.939169

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

PubMed ID

25020233